4,4′-Bis(2-Bromoacetyl)biphenyl CAS 4072-67-7 Daclatasvir Dihydrochloride Ucoceko oluPhakathi >98.0% (HPLC)
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili we-4,4'-Bis (2-Bromoacetyl) biphenyl (CAS: 4072-67-7) enomgangatho ophezulu.I-Ruifu Chemical inokubonelela ngenkonzo yehlabathi jikelele, ixabiso elikhuphisanayo, inkonzo egqwesileyo, encinci kunye nezixa ezininzi ezikhoyo.Thenga i-4,4'-Bis(2-Bromoacetyl)biphenyl,Please contact: alvin@ruifuchem.com
| Igama leMchiza | 4,4'-Bis(2-Bromoacetyl)biphenyl |
| Izithethantonye | 4,4'-Bis(Bromoacetyl)biphenyl;1,1'-[1,1'-Biphenyl] -4,4'-diylbis[2-Bromoethan-1-enye];Ukungacoceki kweDaclatasvir 7 |
| Ubume beStokhwe | Kwi-Stock, iMveliso yoRhwebo |
| Inombolo yeCAS | 4072-67-7 |
| Ifomula yeemolekyuli | C16H12Br2O2 |
| Ubunzima beMolekyuli | 396.07 g/mol |
| Indawo yokunyibilika | 226.0 ~ 227.0℃ |
| Ukuxinana | 1.622±0.06 g/cm3 |
| I-COA kunye ne-MSDS | Iyafumaneka |
| Imvelaphi | Shanghai, China |
| Udidi | Umbindi weDaclatasvir Dihydrochloride (CAS: 1009119-65-6) |
| Uphawu | Ruifu Chemical |
| Izinto | Iinkcukacha | Iziphumo |
| Imbonakalo | Iqinile | Iqinile |
| Ubunyulu / Indlela yokuHlalutya | >98.0% (HPLC) | 98.5% |
| I-Infrared Spectrum | Ngokungqinelana noLwakhiwo | Iyahambelana |
| I-1H NMR Spectrum | Ngokungqinelana noLwakhiwo | Iyahambelana |
| Ukuqukumbela | Imveliso ivavanyiwe kwaye ihambelana neenkcukacha ezinikiweyo | |
| Isicelo | Umbindi weDaclatasvir Dihydrochloride (CAS: 1009119-65-6) | |
Umqulu:Ibhotile eFluorinated, iAluminium foil bag, 25kg/Cardboard Drum, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina isikhongozeli sivaliwe kwaye usigcine kwindawo epholileyo, eyomileyo nengena umoya kakuhle kude nezinto ezingahambelaniyo.Khusela ukukhanya kunye nokufuma.
Ukuhambisa ngenqanawe:Zisa kwihlabathi liphela ngomoya, ngeFedEx / DHL Express.Ukubonelela ngokukhawuleza nangokuthembekileyo.
Ukuthenga njani?Nceda uqhagamshelaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
I-4,4'-Bis (2-Bromoacetyl) i-biphenyl (i-CAS: 4072-67-7) iphakathi kwe-Daclatasvir Dihydrochloride (CAS: 1009119-65-6).
I-Daclatasvir Dihydrochloride (i-Daklinza) yi-inhibitor ye-virus ye-hepatitis C (HCV) i-NS5A eluncedo kunyango lwe-genotype 3 isifo esingapheliyo se-hepatitis C.
NgoJulayi 24, i-2015, i-FDA ivume ichiza elingapheliyo le-hepatitis C (i-Bristol-Myers Squibb) yokuthengisa.
Inkqubo yokuvunywa kwe-FDA ye-Daklinza (i-Bristol-Myers Squibb) iye yajika kwaye yajika.Ikhe yakhatywa yi-FDA, kodwa ekugqibeleni yamkelwa phakathi ku-2015.I-FDA yavuma indibaniselwano ye-Daklinza kunye ne-Sofosbuvir kunyango lwe-hepatitis C yohlobo lwesi-3 lwezigulane.
Enyanisweni, kwangaphambi kokuvunywa kwe-FDA, i-Daklinza yayivunyiwe ukuba ithengiswe eJapan, i-European Union kunye noMzantsi Korea nakwamanye amazwe.Kwi-2014, icandelo lezempilo laseJapan livume isicelo se-Daklinza kunye ne-Asunaprevir (i-Sunvepra) yonyango lwe-genotype 1 usulelo.I-European Union iphinde yavuma ukuba i-Daclatasvir isetyenziswe kunye namanye amachiza kunyango lwe-HCV genotypes 1, 2, 3 kunye ne-4 ngo-2014. I-Daclatasvir yi-NS5A complex inhibitor yokuqala evunywe yi-European Union (EU).Xa isetyenziswe ngokudibeneyo namanye amachiza, xa kuthelekiswa nendibaniselwano yonyango ye-interferon kunye ne-ribavirin ethatha iiveki ezingama-48, inobude obufutshane bonyango (iiveki ezili-12 okanye iiveki ezingama-24).
I-Daclathavir monotherapy ayikhuthazwa, iprothokholi engundoqo yangoku lunyango oludibeneyo lwe-Dacastavir+ Sofosbuvir, oluphawulwa ngokusebenza kakuhle, i-SVR ephezulu, iziphumo ebezingalindelekanga ezincinci kunye nomjikelo wonyango omfutshane ngakumbi kunezinye iindlela.
